Literature DB >> 7825174

The pattern of respiratory infection in patients with lung cancer.

S Kohno1, H Koga, M Oka, J Kadota, M Kaku, H Soda, K Tomono, K Hara.   

Abstract

We examined retrospectively the pattern of respiratory infection in 579 patients with lung cancer admitted to Nagasaki University Hospital during the past 15 years. A total of 139 patients (24.0%) developed respiratory infection. The rates of pulmonary infection associated with large (36.2%) and small cell carcinomas (33.6%) were significantly higher than those with squamous cell carcinoma (26.0%) and adenocarcinoma (17.3%). Advanced stages of lung cancer were associated with higher complication rates (stage I: 6.3%, stage II: 15.9%, stage III: 27.9%, and stage IV: 33.8%). Deceased patients showed a significantly higher rate of pulmonary infection than alive patients during the period of investigation. Isolated organisms in excess of 10(7) cfu/ml in sputum or 10(4) cfu/ml in bronchial aspirate were mainly gram-negative bacteria (68.8%), such as Haemophilus influenzae, Klebsiella pneumoniae, Enterobacter cloacae, Acinetobacter sp. and Pseudomonas aeruginosa. The number of patients infected with gram-positive bacteria increased markedly after 1982. Our results suggest that a successful control of pulmonary infection associated with lung cancer is important in improving the prognosis of lung malignancy.

Entities:  

Mesh:

Year:  1994        PMID: 7825174     DOI: 10.1620/tjem.173.405

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  6 in total

1.  A retrospective study of risk and prognostic factors in relation to lower respiratory tract infection in elderly lung cancer patients.

Authors:  Dan Qiao; Zhiyu Wang; Yaohong Lu; Xiaoting Wen; Hongtao Li; Hui Zhao
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 2.  Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19.

Authors:  Haoyue Guo; Xiaoxia Chen; Chunxia Su; Yu Liu; Hao Wang; Chenglong Sun; Peixin Chen; Minlin Jiang; Yi Xu; Shengyu Wu; Keyi Jia; Sha Zhao; Wei Li; Bin Chen; Lei Wang; Jia Yu; Anwen Xiong; Guanghui Gao; Fengying Wu; Jiayu Li; Lingyun Ye; Bing Bo; Shen Chen; Shengxiang Ren; Yayi He; Caicun Zhou
Journal:  Transl Lung Cancer Res       Date:  2020-04

3.  Colonization with multi-drug-resistant organisms negatively impacts survival in patients with non-small cell lung cancer.

Authors:  Jan A Stratmann; Raphael Lacko; Olivier Ballo; Shabnam Shaid; Wolfgang Gleiber; Maria J G T Vehreschild; Thomas Wichelhaus; Claudia Reinheimer; Stephan Göttig; Volkhard A J Kempf; Peter Kleine; Susanne Stera; Christian Brandts; Martin Sebastian; Sebastian Koschade
Journal:  PLoS One       Date:  2020-11-25       Impact factor: 3.240

4.  Expression of miRNA-601 and PD-L1 among Iranian Patients with Lung Cancer and Their Relationship with Smoking and Mycoplasma Infection.

Authors:  Mahla Ganjali; Babak Kheirkhah; Kumarss Amini
Journal:  Cell J       Date:  2021-12-29       Impact factor: 2.479

5.  Characterising the impact of pneumonia on outcome in non-small cell lung cancer: identifying preventative strategies.

Authors:  Akshay J Patel; Peter Nightingale; Babu Naidu; Mark T Drayson; Gary W Middleton; Alex Richter
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

Review 6.  Immunomodulatory effects of intestinal lung axis microecology and other factors on the prognosis of advanced non-small cell lung cancer.

Authors:  Changxing Shen; Yanbei Ren; Xu Zhang; Qing Xia; Ming Li; Changhui Wang; Lihong Fan
Journal:  Transl Cancer Res       Date:  2019-09       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.